Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe
Authors:
- Tomas JelinekTJTomas Jelinek
- Gabriele Peyerl-HoffmannGPGabriele Peyerl-Hoffmann
- Nikolai MühlbergerNMNikolai Mühlberger
- Ole WichmannOWOle Wichmann
- Michael WilhelmMWMichael Wilhelm
- Nadja SchmiderNSNadja Schmider
- Martin P GrobuschMGMartin P Grobusch
- Frank Von SonnenburgFSFrank Von Sonnenburg
- Joaquim GasconJGJoaquim Gascon
- Hermann LaferlHLHermann Laferl
- Christoph HatzCHChristoph Hatz
- Michael AlifrangisMAMichael Alifrangis
Open Access
- 1 January 2002
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 1 (1) , 11
Abstract
Results from numerous studies point convincingly to correlations between mutations at selected genes and phenotypic resistance to antimalarials in Plasmodium falciparum isolates. In order to move molecular assays for point mutations on resistance-related genes into the realm of applied tools for surveillance, we investigated a selection of P. falciparum isolates that were imported during the year 2001 into Europe to study the prevalence of resistance-associated point mutations at relevant codons. In particular, we tested for parasites which were developing resistance to antifolates and chloroquine. The screening results were used to map the prevalence of mutations and, thus, levels of potential drug resistance in endemic areas world-wide. 337 isolates have been tested so far. Prevalence of mutations that are associated with resistance to chloroquine on the pfcrt and pfmdr genes of P. falciparum was demonstrated at high levels. However, the prevalence of mutations associated with resistance to antifolates at the DHFR and DHPS genes was unexpectedly low, rarely exceeding 60% in endemic areas. Constant screening of imported isolates will enable TropNetEurop to establish a screening tool for emerging resistance in endemic areas.Keywords
This publication has 16 references indexed in Scilit:
- Imported Falciparum Malaria in Europe: Sentinel Surveillance Data from the European Network on Surveillance of Imported Infectious DiseasesClinical Infectious Diseases, 2002
- Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment ofPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 2002
- Biochemical and molecular mechanisms of drug resistance in parasitesTropical Medicine & International Health, 2001
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001
- A Molecular Marker for Chloroquine-Resistant Falciparum MalariaNew England Journal of Medicine, 2001
- Changing ideas on chloroquine in Plasmodium falciparumCurrent Opinion in Infectious Diseases, 2000
- Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from TanzaniaTropical Medicine & International Health, 1998
- Plasmodium falciparum:Detection of Polymorphisms in theDihydrofolate ReductaseandDihydropteroate SynthetaseGenes by PCR and Restriction DigestionExperimental Parasitology, 1998
- Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Epidemiology of drug resistance in malariaActa Tropica, 1994